Keywords
Head and Neck Neoplasms ×
Eligibility Determination ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

44 Search results.

Eligibility Head and Neck Squamous Cell Carcinoma NCT01484847

- 6/11/20 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01484847

Eligibility Head and Neck Squamous Cell Carcinoma NCT00957853

- 6/11/20 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Preoperative Treatment With Cetuximab and/or IMC-A12; ODM derived from: https://clinicaltrials.gov/show/NCT00957853

Eligibility Head and Neck Squamous Cell Carcinoma (HNSCC) NCT00911326

- 6/10/20 - 1 form, 2 itemgroups, 20 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00911326

Eligibility Head and Neck Squamous Cell Carcinoma NCT01697800

- 2/3/20 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract; ODM derived from: https://clinicaltrials.gov/show/NCT01697800

Eligibility Head and Neck Cancer NCT00670397

- 2/2/20 - 1 form, 1 itemgroup, 19 items, 1 language
Itemgroup: Criteria
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00670397

Eligibility Head and Neck Cancer NCT02124707

- 2/2/20 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN; ODM derived from: https://clinicaltrials.gov/show/NCT02124707

Eligibility Head-and-neck Squamous Cell Carcinoma NCT01941992

- 1/2/20 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01941992

Eligibility Head and Neck Squamous Cell Carcinoma NCT02024035

- 1/2/20 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Protocole Advanced RadioTherapy ORL; ODM derived from: https://clinicaltrials.gov/show/NCT02024035

Eligibility Head and Neck Squamous Cell Carcinoma NCT01154920

- 12/23/19 - 1 form, 2 itemgroups, 24 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC); ODM derived from: https://clinicaltrials.gov/show/NCT01154920

Eligibility Head and Neck Squamous Cell Carcinoma NCT01425736

- 12/23/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01425736

Eligibility Head and Neck Carcinoma NCT01507467

- 12/23/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT01507467

Eligibility Head and Neck Neoplasms NCT01479348

- 12/23/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Criteria, Exclusion Criteria
Imaging Study for FdCyd and THU Cancer Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01479348